Nanomedicine from Bench to Bedside - Facilitating Research Translation to Clinics

Young Scientists Event

Date/Time: Saturday, July 21, 2018 - 1:00 PM to 5:00 PM


This CRS-YSC organized Scientific Workshop aims to provide researchers an opportunity to gain knowledge and understanding of clinical translation of nanomedicines. The workshop will bring together experts and scientists in nanomedicine to discuss a range of topics including:

  • Lab scale development to industrial scale up, manufacturing and translation;
  • Standardization and characterization from basic research to clinical development;
  • Preclinical, clinical, and safety considerations in the development process; and
  • Regulatory challenges for development and commercialization.

This popular event requires a $5 registration fee and is open to all interested conference attendees. Limited spaces so hurry to secure your place now!

1:00 PM
Vivek Agrahari and Kaushal Dave
Introduction and Opening Remarks

1:30 PM
Tom Tice, Ph.D.,  Senior Director, Technical Global Marketing, Evonik Industries
Zhen Gu, Ph.D., Prof., Dept. of Biomedical Engineering, University of North Carolina at Chapel Hill & North Carolina State University, Raleigh, NC.
Chemistry, Manufacturing, and Control (CMC) Aspects of Nanomedicine Development and Translation

2:20 PM
Stefen Muehlebach
, Ph.D., Director, Vifor  Pharma Management Ltd.
Regulatory and Bioethical Aspects of Nanomedicine’s Clinical Translation 

2:45 PM

2:55 PM
Xiaoming Xu, Ph.D., Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, MD.
Regulatory and Bioethical Aspects of Nanomedicine’s Clinical Translation 

3:20 PM
Mark A. Tracy, Ph.D., Tracy Bio-Consulting, LLC, Arlington, MA.
Dan Peer, Ph.D., Laboratory of Nano Medicine, Department of Cell Research and Immunology, Tel Aviv University, Tel Aviv, Israel.
Clinical Aspects of Nanomedicine’s Translation

4:10 PM

4:20 PM
Panel Discussion

5:00 PM
Vivek Agrahari and Kaushal Dave
Closing Remarks